Cytopenic myelofibrosis: prevalence, relevance, and treatment
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2023.2203318
Abstract: ABSTRACT Introduction Cytopenic myelofibrosis is increasingly recognized as a phenotype of myelofibrosis presenting with low blood counts, lower driver mutation allele burden, increased likelihood of arising de novo, i.e. primary myelofibrosis, greater genomic complexity, worse… read more here.
Keywords: jak inhibitors; myelofibrosis prevalence; cytopenic myelofibrosis; myelofibrosis ... See more keywords